Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
Metformin: a new option in cancer treatment
Authors
Cristóbal Belda-Iniesta
Olga Pernía
Rafael Simó
Publication date
01-06-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0669-y

Other articles of this Issue 6/2011

Clinical and Translational Oncology 6/2011 Go to the issue

Editorial

The importance of the White Book of Radiation Oncology

Educational Series

Current opinion in cervix carcinoma

Editorial

Oxaliplatin, colorectal cancer and predictive factors

Educational Series

microRNAs as novel epigenetic biomarkers for human cancer

Special Article

The White Book of Radiation Oncology in Spain

Research Articles

The EORTC information questionnaire, EORTC QLQ-INFO25. Validation study for Spanish patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits